• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经颈静脉肝内门体分流术治疗布加综合征:综述

Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.

作者信息

Inchingolo Riccardo, Posa Alessandro, Mariappan Martin, Tibana Tiago Kojun, Nunes Thiago Franchi, Spiliopoulos Stavros, Brountzos Elias

机构信息

Interventional Radiology Unit, "F. Miulli" Regional Hospital, Acquaviva delle Fonti 70021, Italy.

Department of Radiology, Gemelli Hospital, Roma 00135, Italy.

出版信息

World J Gastroenterol. 2020 Sep 14;26(34):5060-5073. doi: 10.3748/wjg.v26.i34.5060.

DOI:10.3748/wjg.v26.i34.5060
PMID:32982109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7495032/
Abstract

Budd-Chiari syndrome (BCS) is a relatively rare clinical condition with a wide range of symptomatology, caused by the obstruction of the hepatic venous outflow. If left untreated, it has got an high mortality rate. Its management is based on a step-wise approach, depending on the clinical presentation, and includes different treatment from anticoagulation therapy up to Interventional Radiology techniques, such as transjugular intrahepatic portosystemic shunt (TIPS). TIPS is today considered a safe and highly effective treatment and should be recommended for BCS patients, including those awaiting orthotopic liver transplantation. In this review the pathophysiology, diagnosis and treatment options of BCS are presented, with a special focus on published data regarding the techniques and outcomes of TIPS for the treatment of BCS. Moreover, unresolved issues and future research will be discussed.

摘要

布加综合征(BCS)是一种相对罕见的临床病症,症状表现多样,由肝静脉流出道梗阻引起。若不治疗,死亡率很高。其治疗基于逐步治疗方法,取决于临床表现,包括从抗凝治疗到介入放射学技术(如经颈静脉肝内门体分流术(TIPS))等不同治疗手段。如今TIPS被认为是一种安全且高效的治疗方法,应推荐给BCS患者,包括那些等待原位肝移植的患者。本文综述了BCS的病理生理学、诊断和治疗选择,特别关注了有关TIPS治疗BCS的技术和结果的已发表数据。此外,还将讨论未解决的问题和未来研究方向。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/ef147f3009ce/WJG-26-5060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/645d48621d94/WJG-26-5060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/8f234a2cfccf/WJG-26-5060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/ef147f3009ce/WJG-26-5060-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/645d48621d94/WJG-26-5060-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/8f234a2cfccf/WJG-26-5060-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c7e/7495032/ef147f3009ce/WJG-26-5060-g003.jpg

相似文献

1
Transjugular intrahepatic portosystemic shunt for Budd-Chiari syndrome: A comprehensive review.经颈静脉肝内门体分流术治疗布加综合征:综述
World J Gastroenterol. 2020 Sep 14;26(34):5060-5073. doi: 10.3748/wjg.v26.i34.5060.
2
[Interventional radiology techniques in the treatment of Budd-Chiari syndrome].[介入放射学技术在布加综合征治疗中的应用]
Wiad Lek. 2006;59(7-8):521-6.
3
Transjugular intrahepatic portosystemic shunt for severe jaundice in patients with acute Budd-Chiari syndrome.经颈静脉肝内门体分流术治疗急性布加综合征患者的严重黄疸
World J Gastroenterol. 2015 Feb 28;21(8):2413-8. doi: 10.3748/wjg.v21.i8.2413.
4
Transjugular intrahepatic portosystemic shunt in the management of Budd Chiari syndrome.经颈静脉肝内门体分流术治疗布加综合征
Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1151-4. doi: 10.1097/01.meg.0000236874.75601.a1.
5
Balloon venoplasty as primary modality of treatment in children with Budd-Chiari syndrome.球囊血管成形术作为儿童布加综合征的主要治疗方式。
J Pediatr Surg. 2020 Oct;55(10):2183-2186. doi: 10.1016/j.jpedsurg.2020.05.021. Epub 2020 May 23.
6
Budd-Chiari syndrome: current perspectives and controversies.布加综合征:当前观点与争议
Eur Rev Med Pharmacol Sci. 2016 Jul;20(15):3273-81.
7
Transjugular intrahepatic portosystemic shunt (TIPSS) for Budd Chiari syndrome.经颈静脉肝内门体分流术(TIPSS)治疗布加氏综合征。
Indian Pediatr. 2010 Jun;47(6):527-8. doi: 10.1007/s13312-010-0081-7.
8
Good Clinical Outcomes in Budd-Chiari Syndrome with Hepatic Vein Occlusion.布加综合征合并肝静脉闭塞时的良好临床结局
Dig Dis Sci. 2016 Oct;61(10):3054-3060. doi: 10.1007/s10620-016-4208-0. Epub 2016 May 25.
9
Endovascular treatment of symptomatic Budd-Chiari syndrome - in favour of early transjugular intrahepatic portosystemic shunt.有症状的布加综合征的血管内治疗——支持早期经颈静脉肝内门体分流术
Eur J Gastroenterol Hepatol. 2016 Jun;28(6):656-60. doi: 10.1097/MEG.0000000000000621.
10
[Interventional radiology, angioplasty and TIPS in Budd-Chiari syndrome].[布加综合征的介入放射学、血管成形术及经颈静脉肝内门体分流术]
Gastroenterol Hepatol. 2003 Oct;26(8):461-4. doi: 10.1016/s0210-5705(03)70394-x.

引用本文的文献

1
Development and validation of a radiomics-based prediction model for variceal bleeding in patients with Budd-Chiari syndrome-related gastroesophageal varices.基于放射组学的布加综合征相关性胃食管静脉曲张患者静脉曲张出血预测模型的开发与验证
World J Gastroenterol. 2025 May 21;31(19):104563. doi: 10.3748/wjg.v31.i19.104563.
2
Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: A Single-Centre Experience.经颈静脉肝内门体分流术治疗布加综合征:单中心经验
J Clin Med. 2024 Oct 1;13(19):5858. doi: 10.3390/jcm13195858.
3
Interventions in Budd-Chiari syndrome: an updated review.

本文引用的文献

1
Review article: a multidisciplinary approach to the diagnosis and management of Budd-Chiari syndrome.综述文章:布加综合征的诊断和治疗的多学科方法。
Aliment Pharmacol Ther. 2019 Apr;49(7):840-863. doi: 10.1111/apt.15149. Epub 2019 Mar 3.
2
Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis.布加综合征和非肝硬化非肿瘤性内脏静脉血栓形成的病理生理学和治疗的当前知识。
J Hepatol. 2019 Jul;71(1):175-199. doi: 10.1016/j.jhep.2019.02.015. Epub 2019 Feb 26.
3
Long Term Survival of Patients Undergoing TIPS in Budd-Chiari Syndrome.
布加综合征的干预措施:最新综述
Abdom Radiol (NY). 2025 Mar;50(3):1307-1319. doi: 10.1007/s00261-024-04558-4. Epub 2024 Sep 26.
4
Efficacy of transjugular intrahepatic portosystemic shunts in treating cirrhotic esophageal-gastric variceal bleeding.经颈静脉肝内门体分流术治疗肝硬化食管胃静脉曲张破裂出血的疗效
World J Gastrointest Surg. 2024 Feb 27;16(2):471-480. doi: 10.4240/wjgs.v16.i2.471.
5
Liver Transplantation: Contraindication and Ineligibility.肝移植:禁忌证与无资格入选情况
J Clin Exp Hepatol. 2023 Nov-Dec;13(6):1116-1129. doi: 10.1016/j.jceh.2023.04.005. Epub 2023 Apr 15.
6
Accessory hepatic vein recanalization for Budd-Chiari syndrome: a systematic review and meta-analysis.辅助性肝静脉再通治疗布加综合征:系统评价和荟萃分析。
BMC Gastroenterol. 2023 Oct 2;23(1):340. doi: 10.1186/s12876-023-02969-z.
7
TIPS: indications, Contraindications, and Evaluation.经皮经肝胆道镜穿刺引流术(TIPS):适应证、禁忌证和评估。
Curr Gastroenterol Rep. 2023 Oct;25(10):232-241. doi: 10.1007/s11894-023-00884-7. Epub 2023 Aug 21.
8
The Role of the Transjugular Intrahepatic Porto-Systemic Shunt in an Emergency Setting.经颈静脉肝内门体分流术在急诊情况下的作用
Life (Basel). 2023 Mar 24;13(4):868. doi: 10.3390/life13040868.
9
Long-Term Improvement in Liver Function Following Transjugular Intrahepatic Portosystemic Shunt in Patients With Budd-Chiari Syndrome.布加综合征患者经颈静脉肝内门体分流术后肝功能的长期改善
J Clin Exp Hepatol. 2022 Nov-Dec;12(6):1474-1479. doi: 10.1016/j.jceh.2022.07.251. Epub 2022 Aug 12.
10
Diagnostic Value of Contrast-Enhanced Ultrasound for Evaluation of Transjugular Intrahepatic Portosystemic Shunt Perfusion.超声造影评估经颈静脉肝内门体分流术灌注的诊断价值
Diagnostics (Basel). 2021 Sep 1;11(9):1593. doi: 10.3390/diagnostics11091593.
布加综合征患者经颈静脉肝内门体分流术治疗后的长期生存情况
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):56-61. doi: 10.1016/j.jceh.2018.02.008. Epub 2018 Mar 1.
4
Timing of Transjugular Intrahepatic Portosystemic Stent-shunt in Budd-Chiari Syndrome: A UK Hepatologist's Perspective.布加综合征中经颈静脉肝内门体分流支架置入术的时机:一位英国肝病学家的观点
J Transl Int Med. 2018 Oct 9;6(3):97-104. doi: 10.2478/jtim-2018-0022. eCollection 2018 Sep.
5
Excellent long-term outcomes of endovascular treatment in budd-chiari syndrome with hepatic veins involvement: A STROBE-compliant article.布加综合征合并肝静脉受累时血管内治疗的卓越长期疗效:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2018 Oct;97(43):e12944. doi: 10.1097/MD.0000000000012944.
6
Budd-Chiari syndrome: a focussed and collaborative approach.布加综合征:一种重点突出且协作的方法。
Hepatol Int. 2018 Nov;12(6):483-486. doi: 10.1007/s12072-018-9900-z. Epub 2018 Oct 8.
7
Benign and malignant hepatocellular lesions in patients with vascular liver diseases.血管性肝脏疾病患者的良性和恶性肝细胞病变。
Abdom Radiol (NY). 2018 Aug;43(8):1968-1977. doi: 10.1007/s00261-018-1502-7.
8
Timing of Transjugular Intrahepatic Portosystemic Shunt for Budd-Chiari Syndrome: An Italian Hepatologist's Perspective.布加综合征经颈静脉肝内门体分流术的时机:一位意大利肝病学家的观点
J Transl Int Med. 2017 Dec 29;5(4):194-199. doi: 10.1515/jtim-2017-0033. eCollection 2017 Dec.
9
The role of TIPS in the management of liver transplant candidates.经颈静脉肝内门体分流术在肝移植候选者管理中的作用。
United European Gastroenterol J. 2017 Dec;5(8):1100-1107. doi: 10.1177/2050640617704807. Epub 2017 Apr 7.
10
Long-term outcomes of transjugular intrahepatic portosystemic shunt in Indian patients with Budd-Chiari syndrome.经颈静脉肝内门体分流术治疗印度布加综合征患者的长期疗效
Eur J Gastroenterol Hepatol. 2017 Oct;29(10):1174-1182. doi: 10.1097/MEG.0000000000000945.